Xofigo RA-223 dichloride injections

Ended Awarded Last action

Contract number
VA26017F0115
Awardee
Awarding agency
Obligated
$111,938

Award facts

Contract value 100% obligated
$111,938.48 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Seattle, WA 98108, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · Xofigo RA-223 dichloride injections; modification to DE-obligate and close out -$127,999
Original award $239,938

About this award

This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract is for the delivery of Xofigo (radium Ra 223 dichloride) injections, a specialized pharmaceutical product used for the treatment of prostate cancer. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and a ceiling value of $111,938.48. The contract has no set-aside designation and is intended to support healthcare programs for veterans, active-duty military personnel, and federal medical facilities. Bayer Healthcare Pharmaceuticals Inc. is a key supplier of critical pharmaceutical products to various federal agencies, including the VA and the Defense Logistics Agency (DLA) Troop Support Medical, through its multiple federal contract vehicles.

Quick answers

Who was awarded contract VA26017F0115?

VA26017F0115 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 28, 2016.

How much is contract VA26017F0115 worth?

The government has obligated $111,938 on VA26017F0115.

Is contract VA26017F0115 an order under another contract?

Yes. VA26017F0115 is a delivery order under V797P2202D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA26017F0115 competed?

The extent of competition for VA26017F0115 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award